Ophthalmology Retina
Scope & Guideline
Connecting thought leaders in retinal innovation.
Introduction
Aims and Scopes
- Retinal Disease Mechanisms and Pathophysiology:
Research focusing on the underlying mechanisms of various retinal diseases, including age-related macular degeneration, diabetic retinopathy, and inherited retinal diseases. Studies often involve genetic, biochemical, and imaging analyses. - Innovative Diagnostic Techniques:
The journal includes studies on advancements in diagnostic imaging technologies such as OCT (Optical Coherence Tomography), OCT angiography, and ultrawide-field imaging, which enhance the ability to diagnose and monitor retinal diseases. - Therapeutic Interventions and Clinical Trials:
A strong emphasis on clinical trials evaluating new treatments, including anti-VEGF therapies, corticosteroids, and novel drug delivery systems, providing insights into efficacy, safety, and long-term outcomes. - Surgical Techniques and Outcomes:
Papers detailing surgical interventions for retinal conditions, such as vitrectomy and scleral buckling, along with their outcomes, complications, and best practices. - Patient Outcomes and Quality of Life:
Research assessing the impact of retinal diseases and their treatments on patients' visual function and overall quality of life, often utilizing patient-reported outcomes.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a notable increase in studies utilizing AI and machine learning for diagnostic purposes, treatment prediction, and enhancing imaging analysis, showcasing the integration of technology in ophthalmology. - Personalized Medicine Approaches:
Emerging focus on personalized treatment strategies tailored to individual patient characteristics, particularly in managing age-related macular degeneration and diabetic retinopathy. - Long-term Outcomes and Real-world Data:
An increase in research analyzing long-term patient outcomes and real-world evidence from large databases, providing insights into the effectiveness and safety of treatments in everyday clinical settings. - Multimodal Imaging Techniques:
Growing interest in combining various imaging techniques (e.g., OCT, fundus photography, and fluorescein angiography) to provide comprehensive assessments of retinal diseases. - Genetic and Molecular Research:
Emerging studies exploring the genetic underpinnings of retinal diseases, contributing to better understanding, diagnosis, and potential gene therapies.
Declining or Waning
- Traditional Imaging Techniques:
There is a noticeable decrease in papers focusing on older imaging modalities, as advancements in OCT and other novel imaging techniques gain prominence. - Basic Science Research:
A waning interest in basic science studies that do not directly translate into clinical applications, with a shift towards translational research that connects laboratory findings to patient care. - General Ophthalmology Topics:
Less emphasis on broader ophthalmology topics not specifically related to retinal diseases, as the journal narrows its focus to more specialized areas within retina. - Outdated Therapeutic Approaches:
Fewer studies on older treatment modalities that have been largely replaced by newer, more effective therapies, such as the decline in research on laser treatments for conditions like diabetic retinopathy.
Similar Journals
EYE
Elevating Research Standards in Visual and Sensory SciencesEYE is a prestigious peer-reviewed journal published by SpringerNature that serves as a cornerstone in the fields of Ophthalmology, Arts and Humanities, and Neuroscience. Since its inception in 1987, this influential journal has consistently maintained a Q1 Quartile ranking across multiple categories, showcasing its commitment to advancing knowledge and research in its disciplines. With a notable impact factor and a robust Scopus ranking—19th in Ophthalmology and 8th in Sensory Systems—EYE is vital for researchers, clinicians, and students alike, providing a platform for groundbreaking studies and critical reviews. While the journal operates under a subscription model, it ensures broad access to high-quality research, facilitating the dissemination of knowledge that shapes the future of eye health and sensory systems. With an address at Campus, 4 Crinan St, London N1 9XW, England, EYE continues to be a leading light in the understanding and advancement of visual health and sensory sciences.
BMC Ophthalmology
Innovating Ophthalmology Through Open Access ResearchBMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Advancing the frontiers of vision science.Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.
PROGRESS IN RETINAL AND EYE RESEARCH
Exploring the Depths of Retinal HealthPROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.
International Journal of Retina and Vitreous
Pioneering insights into ocular diseases and treatments.The International Journal of Retina and Vitreous, published by BMC, stands as a premier open-access platform dedicated to advancing the field of ophthalmology, specifically focusing on retina and vitreous research. Established in 2015, this journal has swiftly positioned itself within the academic community, achieving a commendable Q2 category ranking in Ophthalmology for 2023, and ranks #49 out of 137 in Scopus for Medicine - Ophthalmology, indicating its growing influence and reach within the scientific landscape. The journal is committed to disseminating high-quality research, reviews, and clinical insights that explore innovations, challenges, and breakthroughs in ocular health. With the goal of fostering knowledge exchange among researchers, practitioners, and students, the International Journal of Retina and Vitreous promotes an open-access model, ensuring that vital findings are readily available to a global audience. This journal not only serves as a vital resource for advancing the understanding and treatment of retinal and vitreous diseases but also aims to inspire future studies in this critical area of eye health.
Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology
Elevating Standards in Ophthalmology ResearchTurk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.
JAMA Ophthalmology
Empowering Global Collaboration in OphthalmologyJAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.
EXPERIMENTAL EYE RESEARCH
Connecting Cellular Mechanisms to Visual ProcessesEXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
Advancing the Frontiers of Ophthalmology.Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.
ACTA OPHTHALMOLOGICA
Exploring New Horizons in OphthalmologyACTA OPHTHALMOLOGICA, published by Wiley, is a premier academic journal dedicated to advancing the field of ophthalmology and related medical disciplines. Established in 1923 and maintaining esteemed status through converged years until 1994, and then from 2008 to the present, this journal has consistently delivered pioneering research, reviews, and clinical advancements essential for both practitioners and researchers in eye care. With an impressive impact factor and ranking within the top 15 of its category, ACTA OPHTHALMOLOGICA stands as a Q1 journal in both Medicine (Miscellaneous) and Ophthalmology, reflecting its significant contribution to the field. Although it is not an open-access journal, it continues to offer valuable insights and empirical findings that inform clinical practices and innovative research approaches. As such, it remains a vital resource for scholars, clinicians, and students keen to stay at the forefront of ophthalmological science.